Pim ‐1 as a therapeutic target in human lupus nephritis

ConclusionThese data identify Pim ‐1 as a critical regulator of LN pathogenesis and targeting Pim‐1/NFATc1/NLRP3 pathway might be a therapy for human LN.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatology - February 21, 2019 Category: Rheumatology Authors: Rong Fu, Yong Xia, Meirong Li, Renxiang Mao, Chaohuan Guo, Mianjing Zhou, Hechang Tan, Meiling Liu, Shuang Wang, Niansheng Yang, Jijun Zhao Tags: Full Length Source Type: research